Description
Book SynopsisIntroduction.- Lung endothelial cells and their heterogeneity in chronic lung diseases.- Mesenchymal vascular cells in chronic lung diseases – pericytes smooth muscle cells and adventitia fibroblasts.- Platelets and thrombosis in lung disease.- Biology of extracellular matrix in pulmonary vascular pathology associated with chronic lung diseases.- Genetics and population-based risk factors for pulmonary vascular disease associated Chronic Lung Disease.- Imaging of the pulmonary vasculature and right ventricle in lung disease.- Omics and precision medicine approaches in pulmonary vascular diseases associated with chronic lung disease.- Cardiopulmonary coupling in lung disease.- The pathophysiology diagnosis and clinical impact of pulmonary hypertension in in emphysema COPD and smoking related lung disease.- Diagnosis clinical impact and treatment of pulmonary hypertension associated with interstitial lung disease).- Pulmonary hypertension associated with sarcoidosis.- The challenge of designing clinical trials in lung disease complicated by pulmonary vascular disease.- Pulmonary vascular disease associated with ARDS and post-COVID syndromes.- Pulmonary vascular disease associated with other parenchymal lung diseases post TB chronic lung disease CF LAM neurofibromatosis, Histiocytosis X.- Pulmonary vascular disease associated with hypoxemia and elevation.- Future Directions.
